Martha Morrell - Feb 27, 2024 Form 4 Insider Report for NeuroPace Inc (NPCE)

Role
Chief Medical Officer
Signature
/s/ Rebecca Kuhn, Attorney-In-Fact
Stock symbol
NPCE
Transactions as of
Feb 27, 2024
Transactions value $
$0
Form type
4
Date filed
2/28/2024, 08:56 PM
Previous filing
Feb 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NPCE Common Stock Award $0 +12.5K +16.07% $0.00 90.3K Feb 27, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NPCE Stock Option (Right to Buy) Award $0 +25K $0.00 25K Feb 27, 2024 Common Stock 25K $17.11 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on February 27, 2025 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter.
F2 25% of the shares subject to the option vest on February 27, 2025. The remaining shares subject to the option vest in thirty six (36) equal consecutive monthly installments thereafter.